233 related articles for article (PubMed ID: 28869602)
1. Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.
Heerma van Voss MR; Vesuna F; Bol GM; Afzal J; Tantravedi S; Bergman Y; Kammers K; Lehar M; Malek R; Ballew M; Ter Hoeve N; Abou D; Thorek D; Berlinicke C; Yazdankhah M; Sinha D; Le A; Abrahams R; Tran PT; van Diest PJ; Raman V
Oncogene; 2018 Jan; 37(1):63-74. PubMed ID: 28869602
[TBL] [Abstract][Full Text] [Related]
2. RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.
Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
[TBL] [Abstract][Full Text] [Related]
3. RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.
Xie M; Vesuna F; Tantravedi S; Bol GM; Heerma van Voss MR; Nugent K; Malek R; Gabrielson K; van Diest PJ; Tran PT; Raman V
Cancer Res; 2016 Nov; 76(21):6340-6350. PubMed ID: 27634756
[TBL] [Abstract][Full Text] [Related]
4. Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.
Heerma van Voss MR; Vesuna F; Trumpi K; Brilliant J; Berlinicke C; de Leng W; Kranenburg O; Offerhaus GJ; Bürger H; van der Wall E; van Diest PJ; Raman V
Oncotarget; 2015 Sep; 6(29):28312-26. PubMed ID: 26311743
[TBL] [Abstract][Full Text] [Related]
5. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
Bol GM; Vesuna F; Xie M; Zeng J; Aziz K; Gandhi N; Levine A; Irving A; Korz D; Tantravedi S; Heerma van Voss MR; Gabrielson K; Bordt EA; Polster BM; Cope L; van der Groep P; Kondaskar A; Rudek MA; Hosmane RS; van der Wall E; van Diest PJ; Tran PT; Raman V
EMBO Mol Med; 2015 May; 7(5):648-69. PubMed ID: 25820276
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer.
Heerma van Voss MR; Brilliant JD; Vesuna F; Bol GM; van der Wall E; van Diest PJ; Raman V
Med Oncol; 2017 Mar; 34(3):33. PubMed ID: 28138868
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of DEAD-Box RNA Helicase 3 attenuates stress granule assembly.
Cui BC; Sikirzhytski V; Aksenova M; Lucius MD; Levon GH; Mack ZT; Pollack C; Odhiambo D; Broude E; Lizarraga SB; Wyatt MD; Shtutman M
Biochem Pharmacol; 2020 Dec; 182():114280. PubMed ID: 33049245
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation.
Aksenova M; Sybrandt J; Cui B; Sikirzhytski V; Ji H; Odhiambo D; Lucius MD; Turner JR; Broude E; Peña E; Lizarraga S; Zhu J; Safro I; Wyatt MD; Shtutman M
J Neuroimmune Pharmacol; 2020 Jun; 15(2):209-223. PubMed ID: 31802418
[TBL] [Abstract][Full Text] [Related]
9. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
[TBL] [Abstract][Full Text] [Related]
10. Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level.
Çelik H; Sajwan KP; Selvanathan SP; Marsh BJ; Pai AV; Kont YS; Han J; Minas TZ; Rahim S; Erkizan HV; Toretsky JA; Üren A
Mol Cell Biol; 2015 Sep; 35(18):3145-62. PubMed ID: 26149384
[TBL] [Abstract][Full Text] [Related]
11. Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3.
Fu R; Yang P; Li Z; Liu W; Amin S; Li Z
Cell Death Dis; 2019 Aug; 10(8):593. PubMed ID: 31391454
[TBL] [Abstract][Full Text] [Related]
12. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
[TBL] [Abstract][Full Text] [Related]
13. Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach.
Heerma van Voss MR; Kammers K; Vesuna F; Brilliant J; Bergman Y; Tantravedi S; Wu X; Cole RN; Holland A; van Diest PJ; Raman V
Transl Oncol; 2018 Jun; 11(3):755-763. PubMed ID: 29684792
[TBL] [Abstract][Full Text] [Related]
14. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
15. A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review).
He Y; Zhang D; Yang Y; Wang X; Zhao X; Zhang P; Zhu H; Xu N; Liang S
Oncol Rep; 2018 Mar; 39(3):883-892. PubMed ID: 29328432
[TBL] [Abstract][Full Text] [Related]
16. (DEAD)-box RNA helicase 3 modulates NF-κB signal pathway by controlling the phosphorylation of PP2A-C subunit.
Wang X; Wang R; Luo M; Li C; Wang HX; Huan CC; Qu YR; Liao Y; Mao X
Oncotarget; 2017 May; 8(20):33197-33213. PubMed ID: 28402257
[TBL] [Abstract][Full Text] [Related]
17. DDX3 DEAD-box RNA helicase plays a central role in mitochondrial protein quality control in Leishmania.
Padmanabhan PK; Zghidi-Abouzid O; Samant M; Dumas C; Aguiar BG; Estaquier J; Papadopoulou B
Cell Death Dis; 2016 Oct; 7(10):e2406. PubMed ID: 27735940
[TBL] [Abstract][Full Text] [Related]
18. RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance.
Vellky JE; McSweeney ST; Ricke EA; Ricke WA
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28092-28101. PubMed ID: 33106406
[TBL] [Abstract][Full Text] [Related]
19. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential.
Oshiumi H; Sakai K; Matsumoto M; Seya T
Eur J Immunol; 2010 Apr; 40(4):940-8. PubMed ID: 20127681
[TBL] [Abstract][Full Text] [Related]
20. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
